Antibody Libraries Technology Market Report 2022: Growing Demand for Highly Targeted Therapies Drives Growth –

Dublin –(Business Wire)–“Antibody Libraries Technology Market Analysis, By Technology, Application, End User and Region – Global Forecast to 2029” report has been added to’s supply.

The antibody library technology market size is estimated at USD 145.71 million by 2021 and is expected to expand at a CAGR of 4.76% during the forecast period 2022-2029. Growing demand for highly targeted therapeutics to treat various serious diseases such as cancer and other diseases, and increasing incidence of chronic diseases are factors boosting market growth. However, high prices are expected to hinder growth.

in technology

Based on technology, the market is segmented into ribosome display, mammalian cell surface display, phage display, and yeast display. Phage display and yeast display hold the highest revenue share in 2021 as yeast surface display is an efficient technique to isolate and engineer antibodies to improve their affinity and stability, and phage display is widely used as it is a Versatile in vitro selection technology for finding high affinity.

By Application

On the basis of application, the market is segmented into drug discovery and development and research applications. In the global market, the drug discovery and development segment will account for the largest revenue share in 2021 as it is used in multiple drug discovery and development trials for the treatment of many rare diseases, including cancer and HIV.

By end user

On the basis of end user, the market is segmented into academic and research institutions, biopharmaceutical companies, and contract research organizations. In 2021, the biopharmaceutical companies segment will hold the largest revenue share as they use antibody library technology for various treatments.

This comprehensive research report focuses on the global and regional market size from 2021 to 2029 and the forecast of various segments including technology, application and end user.

Segmentation: Antibody Libraries Technology Market Report 2021-2029 Technology (Revenue, USD Million)

  • Ribosome display

  • Mammalian cell surface display

  • Phage display

  • Yeast display

Application (Income, US$ million)

  • drug discovery and development

  • Research applications

End Users (Revenue, USD Million)

  • academic research institute

  • biopharmaceutical company

  • contract research organization

By Region (Revenue, USD Million)

North America


  • Germany

  • France

  • U.K.

  • Spain

  • Italy

  • Rest of Europe


  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia Pacific

Latin America

  • Brazil

  • Mexico

  • Argentina

  • Rest of Latin America

Middle East and Africa

  • South Africa

  • GCC

  • the rest of the MEA

Key topics covered:

1. Research methodology

2. Introduction: Antibody Library Technology

3. Executive Summary

4. Market dynamics

5. Market environment analysis

6. COVID-19 Impact Analysis: Antibody Library Technology Market

7. Technical market analysis

8. Application Market Analysis

9. Market analysis of end users

10. Regional Market Analysis

11. North America Antibody Library Technology Market

12. European Antibody Library Technology Market

13. Asia Pacific Antibody Library Technology Market

14. Latin America Antibody Library Technology Market

15. MEA Antibody Library Technology Market

16. Competitor Analysis

17. Company Profile

18. Conclusions and Recommendations

mentioned company

  • Abcam Company (UK)

  • Cell Signaling Technology (US)

  • Analytik Jena AG (Germany)

  • flow cytometer

  • Dickinson Corporation (USA)

  • Bio-Rad Laboratories (USA)

  • F. Hoffmann-La Roche (Switzerland)

  • Agilent Technologies (USA)

  • PerkinElmer (USA)

  • GenScript (China)

  • Creature Legends (US)

  • Ilumia Corporation (us)

  • ImmonoPresice Antibody (Canada)

  • Thermo Fisher Scientific (US)

  • Fuji Rebio (Sweden)

  • Omega BioTek (USA)

  • Merck & Co. (Germany)

  • Danaher Corporation (USA)

  • Swallowtail Genomics (US)

  • Lonza (Switzerland)

  • Atlas Antibodies (Sweden)

For more information on this report, please visit

Source link